Skip to main content
SpringerLink
Log in

Xenogeneic Stem Cell–Induced Cardiac Progenitor Cells Regenerated Infarcted Myocardium in Rat Model

  • Original Research
  • Published:
Regenerative Engineering and Translational Medicine Aims and scope Submit manuscript

Abstract

Purpose

We aim to investigate the role of stem cell–based regenerative medicine to repair or regrow the infarcted myocardium and restore normal cardiac homeostasis.

Methods

WIKI4-treated cells were tested for in vitro differentiation into myocytes by gene and protein expression. A myocardial infarction (MI) model was established, cells were transplanted, and cardiac function was assessed by echocardiography. Histological evaluation of the harvested heart was performed to evaluate the cardiac regeneration.

Results

These pre-differentiated cardiomyocytes were assessed for the presence of cardiac markers using immunocytochemical staining for Gata-4, Alpha actinin, and Myosin heavy chain, and gene expression analysis also showed that these cells are expressing cardiomyogenic markers. Hearts transplanted with WIKI4-treated mesenchymal stem cells (MSCs) significantly (***P<0.001) improved the cardiac systolic and diastolic dimension, end-systolic, diastolic, and stroke volume, ejection fraction, and fraction shortening as compared to the MI group after two and four weeks. Fibrotic area and left ventricular wall thickness significantly (***P<0.001) improved in WIKI4-treated group as compared to the control group. Patches of normal myocytes were observed in the infarct zone showing that induced cardiac progenitor cells regenerated cardiomyocytes replacing the infarcted scar, as evident from the co-localization of fluorescently labeled cells and cardiac proteins in immunohistochemical staining.

Conclusion

This study put forth a valuable approach by small molecules to induce differentiation of MSCs into cardiomyocytes, which upon in vivo transplantation regenerated the infarcted heart. These findings will lead to the development of a novel approach for modified cellular therapy and may increase the probability of better myocardial regeneration.

Lay Summary

Cardiovascular diseases (CVD) are the leading causes of morbidity and mortality. The indigenous capability of the myocardium to meet the degeneration is limited. Currently, available therapeutic options for the treatment of CVD are limited and provide solutions to reduce the symptoms. To investigate the role of stem cell–based repairing or regrowing the myocardium and restoring normal cardiac homeostasis, WIKI4-treated cells were tested for in vitro differentiation into myocytes by gene and protein expression.

Treatment of human bone marrow–derived mesenchymal stem cells with WIKI4 induced differentiation of MSCs into the cardiomyogenic lineage. Xenogeneic MSCs and their derivatives in form of induced cardiac progenitors when implanted into the infarcted rat’s heart showed survival, distribution, integration, and differentiation into myogenic lineage, maintained the thickness of the left ventricular wall, infarct area was reduced, and hearts performed better function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data Availability

I declare I have no other data to share. All the information’s included in the manuscript.

References

  1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 Update: a report from the American Heart Association. Circ. 2016;133:e38–60. https://doi.org/10.1161/cir.0000000000000350.

    Article  Google Scholar 

  2. St John Sutton MG, Sharpe N, Sutton MGSJ, Sharpe N. Clinical cardiology: new frontiers left ventricular remodeling after myocardial infarction pathophysiology and therapy. Circ. 2009;101:2981–8.

    Article  Google Scholar 

  3. Bhatnagar A, Rush Z. Cardiovascular regenerative medicine: the developing heart meets adult heart repair. Circ Res. 2009;105:1041–3.

    Article  Google Scholar 

  4. Hansson EM, Lindsay ME, Chien KR. Regeneration next: toward heart stem cell therapeutics. Cell Stem Cell. 2009;5:364–77.

    Article  CAS  PubMed  Google Scholar 

  5. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006;98:1414–21. https://doi.org/10.1161/01.RES.0000225952.61196.39.

    Article  CAS  PubMed  Google Scholar 

  6. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011;109:923–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kumar BM, Maeng GH, Lee YM, et al. Neurogenic and cardiomyogenic differentiation of mesenchymal stem cells isolated from minipig bone marrow. Res Vet Sci. 2012;93:749–57. https://doi.org/10.1016/j.rvsc.2011.09.012.

    Article  CAS  PubMed  Google Scholar 

  8. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol. 2005;23:845–56. https://doi.org/10.1038/nbt1117.

    Article  CAS  PubMed  Google Scholar 

  9. Singh A, Singh A, Sen D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015). Stem Cell Res Ther. 2016;7:1–25.

    Article  CAS  Google Scholar 

  10. Li XH, Yu XY, Lin QX, et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol. 2007;42:295–303. https://doi.org/10.1016/j.yjmcc.2006.07.002.

    Article  CAS  PubMed  Google Scholar 

  11. Naeem N, Haneef K, Kabir N, et al. DNA methylation inhibitors, 5-azacytidine and zebularine potentiate the transdifferentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes. Cardiovasc Ther. 2013;31:201–9. https://doi.org/10.1111/j.1755-5922.2012.00320.x.

    Article  CAS  PubMed  Google Scholar 

  12. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103:697–705. https://doi.org/10.1172/JCI5298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg. 2007;6:593–7.

    Article  PubMed  Google Scholar 

  14. Ye NS, Chen J, Luo GA, et al. Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells Dev. 2006;15:665–76. https://doi.org/10.1089/scd.2006.15.665.

    Article  CAS  PubMed  Google Scholar 

  15. Yung T, Poon F, Liang M, et al. Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals. Nat Commun. 2019;10:4647. https://doi.org/10.1038/s41467-019-12624-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Bhavanasi D, Klein PS. Wnt signaling in normal and malignant stem cells. Curr Stem Cell Rep. 2016;2:379–87.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Haneef K, Ali A, Khan I, et al. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo. Cardiovasc Ther. 2018;36:1–11. https://doi.org/10.1111/1755-5922.12479.

    Article  CAS  Google Scholar 

  18. Khan I, Ali A, Akhter MA, et al. Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction. Cardiovasc Ther. 2017;35:e12248. https://doi.org/10.1111/1755-5922.12248.

    Article  CAS  Google Scholar 

  19. Devine SM, Bartholomew AM, Mahmud N, et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol. 2001;29:244–55. https://doi.org/10.1016/S0301-472X(00)00635-4.

    Article  CAS  PubMed  Google Scholar 

  20. Devine SM, Cobbs C, Jennings M, et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003;101:2999–3001. https://doi.org/10.1182/blood-2002-06-1830.

    Article  CAS  PubMed  Google Scholar 

  21. Ali SR, Ahmad W, Naeem N, et al. Small molecule 2’-deoxycytidine differentiates human umbilical cord-derived MSCs into cardiac progenitors in vitro and their in vivo xeno-transplantation improves cardiac function. Mol Cell Biochem. 2020;470:99–113. https://doi.org/10.1007/s11010-020-03750-6.

    Article  CAS  PubMed  Google Scholar 

  22. Khanabdali R, Saadat A, Fazilah M, et al. Promoting effect of small molecules in cardiomyogenic and neurogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Drug Des Devel Ther. 2016;10:81–91. https://doi.org/10.2147/DDDT.S89658.

    Article  CAS  PubMed  Google Scholar 

  23. Karakikes I, Senyei GD, Hansen J, et al. Small molecule-mediated directed differentiation of human embryonic stem cells toward ventricular cardiomyocytes. Stem Cells Transl Med. 2014;3:18–31. https://doi.org/10.5966/sctm.2013-0110.

    Article  CAS  PubMed  Google Scholar 

  24. Ren Y, Lee MY, Schliffke S, et al. Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. J Mol Cell Cardiol. 2011;51:280–7. https://doi.org/10.1016/j.yjmcc.2011.04.012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Sharma A, Li G, Rajarajan K, et al. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation. J Vis Exp. 2015;18:e52628. https://doi.org/10.3791/52628-v.

    Article  Google Scholar 

  26. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7. https://doi.org/10.1080/14653240600855905.

    Article  CAS  PubMed  Google Scholar 

  27. Mascotti K, McCullough J, Burger SR. HPC viability measurement: trypan blue versus acridine orange and propidium iodide. Transfus. 2000;40:693–6. https://doi.org/10.1046/j.1537-2995.2000.40060693.x.

    Article  CAS  Google Scholar 

  28. Gao Q, Guo M, Jiang X, et al. A cocktail method for promoting cardiomyocyte differentiation from bone marrow-derived mesenchymal stem cells. Stem Cells Int. 2014;2014:1–11. https://doi.org/10.1155/2014/162024.

    Article  CAS  Google Scholar 

  29. Schade D, Plowright AT. Medicinal chemistry approaches to heart regeneration. J Med Chem. 2015;58:9451–79. https://doi.org/10.1021/acs.jmedchem.5b00446.

    Article  CAS  PubMed  Google Scholar 

  30. Kim Y, Phan D, Van Rooij E, et al. The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest. 2008;118:124–32. https://doi.org/10.1172/JCI33255.

    Article  CAS  PubMed  Google Scholar 

  31. Chaulin A. Cardiac troponins: contemporary biological data and new methods of determination. Vasc Health Risk Manag. 2021;17:299–316. https://doi.org/10.2147/VHRM.S300002.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Qazi R, Naeem N, Khan I, et al. Effect of a dianthin G analogue in the differentiation of rat bone marrow mesenchymal stem cells into cardiomyocytes. Mol Cell Biochem. 2020;475:27–39. https://doi.org/10.1007/s11010-020-03855-y.

    Article  CAS  PubMed  Google Scholar 

  33. van de Schans VAM, Smits JFM, Blankesteijn WM. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur J Pharmacol. 2008;585:338–45.

    Article  PubMed  Google Scholar 

  34. Khan I, Ali A, Akhter MA, et al. Preconditioning of mesenchymal stem cells with 2,4-dinitrophenol improves cardiac function in infarcted rats. Life Sci. 2016;162:60–9. https://doi.org/10.1016/j.lfs.2016.08.014.

    Article  CAS  PubMed  Google Scholar 

  35. Kampaktsis PN, Ullal AV, Minutello RM, et al. Impact of paravalvular aortic insufficiency on left ventricular remodeling and mortality after transcatheter aortic valve replacement. J Heart Valve Dis. 2016;25:301–8.

    PubMed  Google Scholar 

  36. Sekaran NK, Crowley AL, de Souza FR, et al. The Role for cardiovascular remodeling in cardiovascular outcomes. Curr Atheroscler Rep. 2017;19:1–11.

    Article  Google Scholar 

  37. Marwick TH. Ejection fraction pros and cons: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018;72:2360–79.

    Article  PubMed  Google Scholar 

  38. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076–84.

    Article  CAS  PubMed  Google Scholar 

  39. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med. 2000;342:1846–54. https://doi.org/10.1056/nejm200006223422501.

    Article  CAS  PubMed  Google Scholar 

  40. Azari MF, Mathias L, Ozturk E, et al. Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol. 2010;8:316–23. https://doi.org/10.2174/157015910793358204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sancricca C. Mesenchymal stromal cells from human perinatal tissues: from biology to cell therapy. World J Stem Cells. 2010;2:81. https://doi.org/10.4252/wjsc.v2.i4.81.

    Article  Google Scholar 

  42. Ekram S, Khalid S, Bashir I, et al. Human umbilical cord-derived mesenchymal stem cells and their chondroprogenitor derivatives reduced pain and inflammation signaling and promote regeneration in a rat intervertebral disc degeneration model. Mol Cell Biochem. 2021;476:3191–205. https://doi.org/10.1007/s11010-021-04155-9.

    Article  CAS  PubMed  Google Scholar 

  43. Ennis J, Götherström C, Le Blanc K, Davies JE. In vitro immunologic properties of human umbilical cord perivascular cells. Cytotherapy. 2008;10:174–81. https://doi.org/10.1080/14653240801891667.

    Article  CAS  PubMed  Google Scholar 

  44. Weiss ML, Anderson C, Medicetty S, et al. Immune properties of human umbilical cord Wharton’s jelly-derived cells. Stem Cells. 2008;26:2865–74. https://doi.org/10.1634/stemcells.2007-1028.

    Article  CAS  PubMed  Google Scholar 

  45. Yoo KH, Jang IK, Lee MW, et al. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009;259:150–6. https://doi.org/10.1016/j.cellimm.2009.06.010.

    Article  CAS  PubMed  Google Scholar 

  46. Yang CC, Shih YH, Ko MH, et al. Transplantation of human umbilical mesenchymal stem cells from Wharton’s jelly after complete transection of the rat spinal cord. PLoS One. 2008;3:e3336. https://doi.org/10.1371/journal.pone.0003336.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Fu Y-S, Cheng Y-C, Lin M-YA, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism. Stem Cells. 2006;24:115–24. https://doi.org/10.1634/stemcells.2005-0053.

    Article  PubMed  Google Scholar 

  48. Xiong N, Zhang Z, Huang J, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson’s disease. Gene Ther. 2011;18:394–402. https://doi.org/10.1038/gt.2010.152.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We acknowledge animal resource and the imaging facility of Dr. Panjwani Center for Molecular Medicine and Drug Research.

Author information

Authors and Affiliations

  1. Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, 75270, Pakistan

    Syeda Roohina Ali, Waqas Ahmad, Asmat Salim & Irfan Khan

  2. Univ. Bordeaux, CNRS, Bordeaux INP, CBMN, UMR 5248, F-33600, Pessac, France

    Marie-Christine Durrieu

Authors
  1. Syeda Roohina Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Waqas Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Asmat Salim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marie-Christine Durrieu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irfan Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S. R. A. performed experiments and wrote the original manuscript. W. A. helped in experimentation and writing. A. S. evaluated and analyzed the data and reviewed the manuscript. M. C. D. evaluated and analyzed the data. I. K. conceived and designed the studies, evaluated and analyzed the data, and finalized the manuscript.

Corresponding author

Correspondence to Irfan Khan.

Ethics declarations

Ethics Approval

This study was approved by the Institutional Animal Care and Use Committee authorization no. 2018-0020.

Statement of Human and Animal Rights

All of the experimental procedures involving animals were conducted following the Institutional Animal Care guidelines of Dr. Panjwani Center of Molecular Medicine and Drug Research, University of Karachi, Pakistan.

Statement of Informed Consent

There are no human subjects is involved and informed consent is not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, S.R., Ahmad, W., Salim, A. et al. Xenogeneic Stem Cell–Induced Cardiac Progenitor Cells Regenerated Infarcted Myocardium in Rat Model. Regen. Eng. Transl. Med. 10, 110–125 (2024). https://doi.org/10.1007/s40883-023-00311-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40883-023-00311-3

Keywords

Search

Navigation